Perceptive Advisors’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-101,000	Closed	-$3.16M	–	113
2023 Q4	$3.16M	Buy	+101,000	New	+$2.41M	0.07%	83
2022 Q2	–	Sell	-284,853	Closed	-$6.9M	–	112
2022 Q1	$6.9M	Sell	284,853 -1,299,199	-82%	-$31.4M	0.14%	94
2021 Q4	$37M	Buy	+1,584,052	New	+$31.9M	0.57%	46
2021 Q2	–	Sell	-1,410,305	Closed	-$36.4M	–	151
2021 Q1	$36.4M	Buy	+1,410,305	New	+$62.1M	0.48%	54
2020 Q1	–	Sell	-11,256	Closed	-$482K	–	114
2019 Q4	$482K	Buy	+11,256	New	+$490K	0.01%	107
2019 Q2	–	Sell	-14,897	Closed	-$400K	–	106
2019 Q1	$400K	Buy	+14,897	New	+$348K	0.01%	95
2018 Q2	–	Sell	-275,000	Closed	-$6.18M	–	126
2018 Q1	$6.18M	Buy	+275,000	New	+$7.61M	0.17%	75
2017 Q1	–	Hold	0	–	–	–	164
2016 Q4	–	Sell	-65,240	Closed	-$1.73M	–	183
2016 Q3	$2.08M	Sell	65,240 -100,000	-61%	-$3.39M	0.13%	86
2016 Q2	$5.36M	Sell	165,240 -90,000	-35%	-$3.01M	0.44%	55
2016 Q1	$7.14M	Buy	255,240 +10,000	+4%	+$218K	0.64%	44
2015 Q4	$8.74M	Sell	245,240 -50,000	-17%	-$1.76M	0.67%	37
2015 Q3	$9.76M	Sell	295,240 -115,000	-28%	-$4.78M	0.89%	31
2015 Q2	$17.2M	Sell	410,240 -190,000	-32%	-$7.35M	1.12%	24
2015 Q1	$19.6M	Sell	600,240 -493,041	-45%	-$16.9M	1.57%	18
2014 Q4	$34.7M	Sell	1,093,281 -4,633	-0.4%	-$131K	3.11%	9
2014 Q3	$27.2M	Buy	1,097,914 +444,914	+68%	+$10.4M	2.96%	9
2014 Q2	$14.8M	Sell	653,000 -13,000	-2%	-$271K	1.48%	23
2014 Q1	$16.2M	Buy	+666,000	New	+$16.8M	1.82%	18
2013 Q4	–	Sell	-610,615	Closed	-$16.8M	–	111
2013 Q3	$16.8M	Sell	610,615 -116,014	-16%	-$2.43M	1.47%	17
2013 Q2	$13.2M	Buy	+726,629	New	+$10M	1.47%	17